ATOSSA THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q3 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Atossa Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2011 to Q4 2024.
  • Atossa Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$7.15M, a 20.7% increase year-over-year.
  • Atossa Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$27.6M, a 12% increase year-over-year.
  • Atossa Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$27.6M, a 12% increase from 2023.
  • Atossa Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$31.4M, a 13.3% decline from 2022.
  • Atossa Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$27.7M, a 34.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$27.6M -$7.15M +$1.87M +20.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-25
Q3 2024 -$29.5M -$6.39M +$1.08M +14.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$30.6M -$7.11M +$688K +8.83% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$31.3M -$6.98M +$118K +1.66% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$31.4M -$9.02M -$874K -10.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-25
Q3 2023 -$30.5M -$7.47M +$737K +8.98% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$31.2M -$7.79M -$1.2M -18.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$30M -$7.1M -$2.35M -49.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$27.7M -$8.14M -$3.32M -68.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$24.4M -$8.21M -$3.05M -59.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$21.3M -$6.6M +$409K +5.84% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$21.7M -$4.75M -$1.22M -34.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$20.5M -$4.83M -$603K -14.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$19.9M -$5.16M -$1.65M -47% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$18.3M -$7M -$3.07M -78% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$15.2M -$3.53M -$594K -20.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$14.6M -$4.23M -$1.61M -61.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$13M -$3.51M -$211K -6.39% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$12.8M -$3.94M +$3.35M +46% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$16.1M -$2.94M +$1.13M +27.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$17.3M -$2.62M -$510K -24.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$16.8M -$3.3M +$11.8K +0.36% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$16.8M -$7.29M -$3.14M -75.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$13.6M -$4.06M -$2.19M -117% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$11.4M -$2.11M -$114K -5.71% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$11.3M -$3.31M -$1.25M -61% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$10.1M -$4.14M -$2.25M -118% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$7.82M -$1.87M -$171K -10% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$7.65M -$1.99M +$367K +15.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 -$8.02M -$2.06M -$497K -31.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$7.52M -$1.9M -$174K -10.1% Apr 1, 2017 Jun 30, 2017 10-Q/A 2018-11-13
Q1 2017 -$7.34M -$1.7M +$624K +26.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$7.97M -$2.36M +$113K +4.55% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$8.08M -$1.56M +$2.28M +59.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$10.4M -$1.72M +$1.45M +45.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$11.8M -$2.33M +$945K +28.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$12.8M -$2.47M +$856K +25.7% Oct 1, 2015 Dec 31, 2015 10-K/A 2017-03-21
Q3 2015 -$13.6M -$3.84M -$597K -18.4% Jul 1, 2015 Sep 30, 2015 10-Q/A 2017-03-21
Q2 2015 -$13M -$3.17M +$16K +0.5% Apr 1, 2015 Jun 30, 2015 10-Q/A 2017-03-21
Q1 2015 -$13M -$3.27M -$862K -35.7% Jan 1, 2015 Mar 31, 2015 10-Q/A 2017-03-21
Q4 2014 -$12.2M -$3.33M -$570K -20.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$11.6M -$3.25M +$257K +7.33% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$11.9M -$3.19M -$603K -23.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$11.3M -$2.41M -$469K -24.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$10.8M -$2.76M -$1.05M -61.7% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 -$9.73M -$3.5M -$2.37M -208% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$7.37M -$2.58M -$1.42M -122% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$5.95M -$1.94M -$879K -82.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$5.07M -$1.71M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-27
Q3 2012 -$1.14M +$139K +10.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$1.17M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$1.06M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 -$1.27M Jul 1, 2011 Sep 30, 2011 10-Q/A 2013-01-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.